Shanghai United Imaging Healthcare (688271) Q3 2025 earnings summary

Executive summary

• Achieved total revenue of RMB 2.84 billion for the quarter, up 75.41% year-over-year, and RMB 8.86 billion for the first nine months, up 27.39% year-over-year.

• Net profit attributable to shareholders for the quarter was RMB 122.2 million, with a year-to-date figure of RMB 1.12 billion, up 66.91% year-over-year.

• Strong performance driven by continued domestic market momentum and steady overseas business growth.

Financial highlights

• Operating profit for the first nine months reached RMB 1.18 billion, up 65.56% year-over-year.

• Basic and diluted EPS for the first nine months were RMB 1.36, up 65.85% year-over-year.

• Net cash flows from operating activities for the first nine months were RMB 107.2 million.

• R&D investment for the first nine months was RMB 1.86 billion, representing 20.94% of revenue.

Outlook and guidance

• Performance growth expected to continue, supported by robust domestic demand and expanding overseas markets.